|
MAGOH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78934644878836E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01330055457538E-10 |
| Normal-vs-Stage2 |
1.31370000433506E-08 |
| Normal-vs-Stage3 |
1.28229649121181E-11 |
| Normal-vs-Stage4 |
2.3356871992064E-12 |
| Stage1-vs-Stage2 |
3.590000E-01 |
| Stage1-vs-Stage3 |
1.509240E-01 |
| Stage1-vs-Stage4 |
1.883960E-02 |
| Stage2-vs-Stage3 |
8.979200E-01 |
| Stage2-vs-Stage4 |
2.517000E-01 |
| Stage3-vs-Stage4 |
2.394200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.76076988731711E-13 |
| Normal-vs-AfricanAmerican |
9.30510000052287E-07 |
| Normal-vs-Asian |
1.74429999999504E-07 |
| Caucasian-vs-AfricanAmerican |
7.940000E-01 |
| Caucasian-vs-Asian |
3.707200E-01 |
| AfricanAmerican-vs-Asian |
3.705800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47110101877956E-11 |
| Normal-vs-Female |
3.01592084639424E-12 |
| Male-vs-Female |
9.561600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.90700011337697E-10 |
| Normal-vs-Age(41-60Yrs) |
2.27129426377815E-12 |
| Normal-vs-Age(61-80Yrs) |
2.79332112995689E-12 |
| Normal-vs-Age(81-100Yrs) |
5.217400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.648400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.161900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.497000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.862350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.318400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.470000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.575300E-03 |
| Classical-VS-Follicular |
8.724400E-01 |
| Classical-VS-Other |
7.284600E-01 |
| Classical-VS-Normal |
3.48499007429837E-12 |
| Tall-VS-Follicular |
8.499200E-03 |
| Tall-VS-Other |
7.448200E-02 |
| Tall-VS-Normal |
8.46369641038791E-11 |
| Follicular-VS-Other |
8.386600E-01 |
| Follicular-VS-Normal |
1.50830000000823E-06 |
| Other-VS-Normal |
2.069900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30060448258973E-11 |
| Normal-vs-N1 |
1.39830000023267E-07 |
| N0-vs-N1 |
5.310600E-01 |
|
|
